港股異動 | 獲機構看好 中國聯塑(2128.HK)續漲6%再創新高
格隆匯4月7日丨中國聯塑(2128.HK)股價繼續走強,盤中最高見19.48港元續創新高,現報19.36港元,漲幅6.14%,最新總市值600.63億港元,年內累計漲幅約60%。公司上月29日公吿稱,2020年淨利同比增加24.1%至37.57億元人民幣。國泰君安指,公司盈利能力提升超出市場預期,上調2021-2023年公司歸母淨利至44.42億,49.39億,55.9億元人民幣,按照最新業績年與盈利預測上調目標價至26.86港幣。花旗將公司今明兩年盈利預測上調11%至12%,目標價由18.3港元升至22港元,評級“買入”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.